Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2009 | 01-2009 | 12-2008 | 10-2008 | 07-2008 | |
| Sales | 256,600 | 254,300 | 299,700 | 338,500 | 381,800 |
| Cost of Goods | 173,800 | 175,600 | 225,400 | 249,700 | 251,200 |
| Gross Profit | 82,800 | 78,700 | 74,300 | 88,800 | 130,600 |
| Operating Expenses | 497,600 | 505,500 | 99,200 | 100,400 | 105,000 |
| Operating Income | -414,000 | -426,200 | -24,500 | -10,900 | 25,800 |
| Other Income | -23,000 | -20,300 | -28,000 | -30,300 | -9,500 |
| Pre-tax Income | -437,000 | -446,500 | -52,500 | -41,200 | 16,300 |
| Income Tax | -3,000 | -4,000 | -4,100 | -100 | 2,900 |
| Net Income Continuous | -434,000 | -442,500 | -48,400 | -41,100 | 13,400 |
| Net Income Discontinuous | -9,700 | -300 | -2,000 | -5,600 | 1,700 |
| Minority Interests | -600 | N/A | -700 | N/A | N/A |
| Net Income | $-443,100 | $-442,800 | $-49,700 | $-46,000 | $15,100 |
| EPS Basic Total Ops | -4.59 | -4.45 | -0.47 | -0.40 | 0.13 |
| EPS Basic Continuous Ops | -4.49 | -4.45 | -0.46 | -0.35 | 0.11 |
| EPS Basic Discontinuous Ops | -0.10 | 0.00 | -0.01 | -0.05 | 0.02 |
| EPS Diluted Total Ops | -4.59 | -4.45 | -0.47 | -0.40 | 0.13 |
| EPS Diluted Continuous Ops | -4.49 | -4.45 | -0.46 | -0.35 | 0.11 |
| EPS Diluted Discontinuous Ops | -0.10 | 0.00 | -0.01 | -0.05 | 0.02 |
| EBITDA(a) | $-449,600 | $-461,800 | $399,800 | $34,000 | $89,000 |